Market Access Key Takeaways in 2020
I’m Charline Shan, Vice President, Director – Access Experience Team, editor of and I hope to bring noteworthy and groundbreaking news to Precision Value and Health’s bimonthly newsletter by sharing the latest payer insights brought to you by our team of former access decision makers.
Looking back, 2020 was filled with many unforeseen events due to COVID-19 and the aftermath, and lasting effect is yet to be determined. The healthcare landscape may be changed but payers continue to drive towards value-based healthcare and managing healthcare resource utilization and costs regardless of a pandemic. As an unprecedented 2020 is winding down, we asked our advisors to consider and reflect on main events that occurred in 2020 and the necessary next steps for market access stakeholders. Jeremy Schafer reviews the rise of PBM-based GPOs, Ryan Cox discusses health system trends in 2020, Erin Lopata examines the larger role of specialty pharmacies in managing care and costs, and Dominic Galante determines the key takeaways for regional Medicare health plans.
I think you’ll find the insights in All Access to be thought provoking and helpful in navigating the payer landscape. As always, please feel free to drop me a note and let me know if you have a topic suggestion for the payer team to address, and we’ll do our best to cover it in a future edition.
Stay safe and be well,
Charline Shan, RPh, MPH
Vice President, Director
Access Experience Team
All Access is a bimonthly newsletter that features key insights from our team of former payers, intended specifically for market access leaders. It is published by PRECISIONvalue.
Flying under the radar amid the chaos and uncertainty caused by COVID-19, a rather large change in the PBM market is occurring: the rise of rebate GPOs. Jeremy Schafer unpacks these changes and dives into the development of ASCENT and ZINC, and what they mean for manufacturers and contracting changes moving forward.
Almost to the level of saturation, there have been a remarkably high number of articles and publications examining the impact of COVID-19 on the US healthcare system. Precision’s Ryan Cox takes a look at some of the less-mentioned trends hinting at changes coming to health systems in the near future.
How will the proliferation of specialty pharmacy products available in the marketplace be managed by payers? Precision’s Erin Lopata examines the larger role of specialty pharmacies in managing care and costs as payers work to find solutions to high pharmacy and medical spend in their specialty populations.
What are the key takeaways and approaches to delivering unique membership experiences and building loyalty to regional Medicare plans? Precision’s Dominic Galante examines how these plans will keep members engaged and enrolled, one of their top priorities, among the uncertainty caused by COVID-19.